Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8,564,500
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
23,232,402
-
Shares change
-
+797,926
-
Total reported value, excl. options
-
$329,896,488
-
Value change
-
+$8,113,819
-
Number of buys
-
45
-
Number of sells
-
-23
-
Price
-
$14.2
Significant Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q4 2016
89 filings reported holding ATRA - Atara Biotherapeutics, Inc. - Common Stock as of Q4 2016.
Atara Biotherapeutics, Inc. - Common Stock (ATRA) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23,232,402 shares
.
Largest 10 shareholders include BAUPOST GROUP LLC/MA (5,359,632 shares), FMR LLC (2,782,447 shares), Redmile Group, LLC (2,670,942 shares), Arrowpoint Asset Management, LLC (1,560,612 shares), BlackRock Fund Advisors (1,111,507 shares), EAGLE ASSET MANAGEMENT INC (1,110,698 shares), BRIDGER MANAGEMENT, LLC (798,321 shares), VANGUARD GROUP INC (750,291 shares), Neuberger Berman Group LLC (750,140 shares), and STATE STREET CORP (600,521 shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.